HCA Healthcare Inc (NYSE:HCA) Shares Sold by Bridgeworth LLC

Share on StockTwits

Bridgeworth LLC lowered its stake in HCA Healthcare Inc (NYSE:HCA) by 4.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,618 shares of the company’s stock after selling 76 shares during the quarter. Bridgeworth LLC’s holdings in HCA Healthcare were worth $219,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in HCA. Janus Henderson Group PLC grew its stake in HCA Healthcare by 33.6% in the 1st quarter. Janus Henderson Group PLC now owns 2,368,547 shares of the company’s stock valued at $308,812,000 after acquiring an additional 596,056 shares during the period. AQR Capital Management LLC grew its stake in HCA Healthcare by 11.1% in the 1st quarter. AQR Capital Management LLC now owns 3,555,318 shares of the company’s stock valued at $461,160,000 after acquiring an additional 355,406 shares during the period. Geode Capital Management LLC grew its stake in HCA Healthcare by 10.0% in the 4th quarter. Geode Capital Management LLC now owns 3,414,676 shares of the company’s stock valued at $424,189,000 after acquiring an additional 310,086 shares during the period. PNC Financial Services Group Inc. grew its stake in HCA Healthcare by 280.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 379,595 shares of the company’s stock valued at $49,493,000 after acquiring an additional 279,774 shares during the period. Finally, Magellan Asset Management Ltd grew its stake in HCA Healthcare by 2.0% in the 1st quarter. Magellan Asset Management Ltd now owns 12,908,938 shares of the company’s stock valued at $1,683,067,000 after acquiring an additional 258,477 shares during the period. 70.14% of the stock is currently owned by hedge funds and other institutional investors.

Shares of HCA opened at $123.54 on Tuesday. HCA Healthcare Inc has a 52-week low of $110.31 and a 52-week high of $147.42. The business’s fifty day simple moving average is $136.11. The firm has a market cap of $43.52 billion, a PE ratio of 12.31, a PEG ratio of 1.09 and a beta of 0.85.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The business had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. During the same period last year, the firm earned $2.29 EPS. The company’s revenue for the quarter was up 9.3% compared to the same quarter last year. As a group, sell-side analysts expect that HCA Healthcare Inc will post 10.35 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, August 30th. This represents a $1.60 annualized dividend and a yield of 1.30%. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

A number of equities research analysts recently issued reports on HCA shares. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price target on the stock. in a research note on Monday, May 27th. Barclays dropped their price target on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. Mizuho set a $153.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, July 31st. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Finally, Deutsche Bank lifted their price target on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and seventeen have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $153.00.

In other news, SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the transaction, the senior vice president now owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Jon M. Foster sold 44,281 shares of the business’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the transaction, the insider now directly owns 96,052 shares in the company, valued at approximately $11,745,238.56. The disclosure for this sale can be found here. Insiders own 2.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Bollinger Bands

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Comparing Ruhnn  & Reebonz
Comparing Ruhnn & Reebonz
Financial Analysis: Advanced Info Service PCL  versus Crexendo
Financial Analysis: Advanced Info Service PCL versus Crexendo
Analyzing Main Street Capital  & Bloomin’ Brands
Analyzing Main Street Capital & Bloomin’ Brands
The9  versus Zillow Group  Head-To-Head Comparison
The9 versus Zillow Group Head-To-Head Comparison
Head-To-Head Comparison: Yum! Brands  versus Nathan’s Famous
Head-To-Head Comparison: Yum! Brands versus Nathan’s Famous
Head to Head Comparison: Gazprom Neft’ PAO   and KLX Energy Services
Head to Head Comparison: Gazprom Neft’ PAO and KLX Energy Services


© 2006-2019 Ticker Report